Cambridge Investment Research Advisors’s EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF XOVR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.21M Buy
152,746
+40,649
+36% +$776K 0.01% 1326
2026
Q1
$1.89M Buy
112,097
+90,779
+426% +$1.65M ﹤0.01% 1624
2025
Q4
$429K Buy
21,318
+4,584
+27% +$94K ﹤0.01% 2871
2025
Q3
$353K Buy
16,734
+2,564
+18% +$51.1K ﹤0.01% 2973
2025
Q2
$271K Buy
+14,170
New +$243K ﹤0.01% 3067

Other funds holding XOVR

Cambridge Investment Research Advisors's XOVR Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF (XOVR) stake by 36% in Q2 2026, buying an estimated $776K and bringing the position to 152,746 shares worth $3.21M. The position accounts for 0.01% of the portfolio, ranked #1326.

Cambridge Investment Research Advisors first reported a position in XOVR in Q2 2025 and has held it in 5 quarters since. 234 funds tracked by Wall St. Rank hold XOVR as of Q2 2026.

  • Cambridge Investment Research Advisors held 152,746 shares of EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF worth $3.21M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 40,649 EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF shares in Q2 2026, an estimated $776K.
  • EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1326 holding.
  • Cambridge Investment Research Advisors first reported a position in EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF in Q2 2025 and has held it in 5 quarters since.
  • 234 funds tracked by Wall St. Rank held EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.